wide
varieti
vesicl
activ
releas
live
cell
extracellular
space
content
reflect
cellular
composit
physiolog
state
review
see
year
differ
type
extracellular
vesicl
given
varieti
name
includ
exosom
shed
microvesicl
ectosom
microparticl
virosom
viruslik
particl
oncosom
distinguish
featur
vesicl
subtyp
correct
nomenclatur
current
intens
studi
refer
gener
term
microvesicl
microvesicl
carri
rna
mrna
microrna
mirna
noncod
sequenc
cdna
genom
sequenc
larg
compon
protein
lipid
see
review
well
upon
releas
microvesicl
move
within
extracellular
space
either
taken
neighbor
cell
degrad
also
enter
adjoin
bodili
fluid
system
circul
travel
distant
site
fact
found
abund
blood
serum
plasma
urin
breast
milk
sweat
saliva
ascit
fluid
cerebr
spinal
fluid
csf
least
two
distinct
releas
mechan
microvesicl
describ
two
subtyp
multivesicular
bodi
mvb
shed
plasma
membran
interestingli
mechan
consider
overlap
viru
releas
biogenesi
summar
figur
discuss
exosom
rang
nm
diamet
gener
inward
bud
lumen
intern
vesicular
compart
deriv
endosom
vesicl
accumul
within
endosomederiv
compart
refer
collect
mvb
mvb
either
target
degrad
lysosom
pathway
fuse
plasma
membran
releas
interior
vesicl
extracellular
space
exact
mechan
kinet
fusion
releas
event
fulli
elucid
may
vari
among
differ
cell
type
exampl
deplet
hr
compon
led
decreas
exosom
secret
dendrit
cell
stimul
releas
ovalbumin
calcium
ionophor
oligodendrocyt
hand
seem
secret
exosom
mechan
escrt
independ
ceramid
depend
exosom
releas
hela
cell
found
involv
report
play
role
exosom
releas
nonsmal
cell
lung
cancer
cell
line
also
shown
involv
releas
exosom
mvb
act
tetheringdock
mvb
plasma
membran
promot
homotyp
fusion
presenc
calcium
addit
inhibitor
led
intracellular
accumul
endosom
vesicl
impair
exosom
secret
shed
microvesicl
releas
outward
bud
directli
plasma
membran
tend
larger
nm
diamet
heterogen
size
moreov
releas
process
like
control
local
cytoskeleton
dynam
small
cytoplasm
membranecov
protrus
detach
releas
extracellular
space
activ
gtpase
interestingli
recent
observ
indic
virusindepend
bud
plasma
membran
mediat
endosom
plasma
membran
reloc
promin
member
escrti
complex
frequent
note
exosom
marker
type
bud
topolog
ident
inward
bud
limit
membran
mvb
viral
assembl
plasma
membran
outer
surfac
plasma
membran
outer
surfac
microvesicl
fact
certain
tumor
cell
shed
retrovirallik
vesicl
abund
increas
transcript
endogen
retrovir
sequenc
result
overal
hypomethyl
genom
gener
seem
clear
distinct
virus
microvesicl
base
composit
function
fade
although
separ
vesicl
releas
later
stage
program
cell
death
sinc
latter
vesicl
refer
apoptot
bleb
even
larger
size
role
microvesicl
intercellular
commun
current
receiv
much
attent
upon
releas
donor
cell
microvesicl
either
taken
neighbor
cell
travel
bodili
fluid
cargo
deliveri
recipi
cell
distant
site
although
mani
detail
miss
cellular
uptak
microvesicl
appear
depend
least
part
specif
ligandreceptor
recognit
mediat
direct
fusion
microvesicl
plasma
membran
endocytot
uptak
microvesicl
exampl
quah
et
al
shown
bystand
b
cell
rapidli
activ
acquir
antigen
activ
b
cell
microvesiclemedi
membran
transfer
similar
way
transfer
platelet
endotheli
tumor
cell
result
increas
proadhes
properti
recipi
cell
microvesicl
also
shuttl
mrna
cell
influenc
physiolog
state
recipi
cell
well
cellular
respons
extern
stress
stimuli
addit
mirna
transfer
exosom
instanc
shown
transfer
recipi
prostat
cancer
cell
lead
inhibit
prolifer
recent
mirna
modul
immun
respons
detect
exosom
breast
milk
furthermor
retrotransposon
sequenc
particularli
enrich
tumor
microvesicl
tumorderiv
human
endogen
retrovir
herv
sequenc
transfer
normal
human
umbil
vein
endotheli
cell
huvec
via
microvesicl
result
prolong
increas
hervk
mrna
level
suggest
tumor
cell
transfer
mobil
genet
element
via
microvesicl
neighbor
normal
cell
therebi
modul
genotyp
phenotyp
primari
viral
infect
humor
cellmedi
host
immun
respons
product
neutral
antibodi
cytotox
tcell
attack
infect
cell
employ
contribut
viral
destruct
earli
evas
strategi
adopt
virus
interfer
complet
elimin
viru
allow
persist
infect
releas
microvesicl
formerli
known
lparticl
contain
viral
tegument
protein
glycoprotein
prime
surround
cell
product
infect
reduc
immun
reject
viruslik
vesicl
lack
viral
capsid
dna
therebi
incap
produc
replicationinfect
cycl
cell
howev
viral
tegument
protein
contain
within
immedi
earli
transcript
factor
produc
rapid
transcript
activ
later
arriv
intact
virion
anoth
evas
strategi
observ
target
mhcii
molecul
process
pathway
viral
envelop
glycoprotein
b
gb
antigenpres
cell
apc
routin
sort
mhcii
surfac
receptor
hladr
mhcii
compart
process
primari
role
pathway
present
peptid
antigen
immun
system
order
elicit
suppress
helper
cell
respons
stimul
bcell
product
antigenspecif
antibodi
gb
coupl
hladr
caus
sort
exosom
pathway
oppos
present
cell
surfac
complex
gbdr
effect
hijack
cellular
antigen
present
machineri
prevent
peptid
load
addit
increas
microvesicl
product
final
step
releas
addit
gbdr
complex
host
immun
microenviron
promot
resist
virus
immun
attack
case
produc
bystand
tcell
tolergen
anergi
case
hiv
microvesicl
packag
spread
virusencod
nef
protein
impair
proper
endocytosi
immatur
mhciiinvari
chain
antibodi
class
switch
lysosom
degrad
viral
peptid
allow
hiv
viru
evad
immun
recognit
ebv
human
cytomegaloviru
cmv
hepat
c
viru
hcv
also
found
mean
evad
immun
respons
exploit
microvesicl
discuss
exosom
shed
microvesicl
incorpor
element
cell
well
intrud
virion
upon
circul
microvesicl
encount
enter
suscept
cell
sensit
viral
infect
thu
increas
system
spread
viru
cell
case
human
cmv
microvesicl
releas
infect
cell
present
ctype
lectin
famili
molecul
express
dendrit
captur
intern
complex
cmv
glycoprotein
b
complex
subsequ
distribut
cell
microvesicl
therebi
increas
suscept
cell
cmv
similar
mechan
found
case
hcv
hcvposit
patient
cellular
membran
protein
associ
one
hcv
envelop
glycoprotein
extracellular
releas
complex
within
microvesicl
allow
increas
virusfus
abil
infect
previous
cell
microvesicl
bear
complex
contain
hcv
rna
notabl
import
report
infecti
even
presenc
neutral
antibodi
interestingli
hcv
shown
releas
three
phenotyp
distinct
type
microvesicl
variabl
infect
high
low
howev
differenti
releas
microvesicl
hcv
pathogenesi
remain
elucid
convers
microvesicular
releas
contribut
viral
attack
host
immun
system
exampl
earli
invas
step
cmv
cmv
antigen
transfer
infect
epitheli
cell
ec
via
ecderiv
microvesicl
apc
apc
detect
infect
cell
render
suscept
infect
subsequ
encount
viru
primari
infecti
viral
invas
replic
strategi
inadvert
transfer
apc
bear
cmv
antigen
transplant
organ
serv
marker
host
immun
system
target
nonself
tissu
harbor
suscept
apc
immunecompromis
host
continu
microvesicular
shed
increas
tcell
surveil
influx
graft
tissu
therebi
exacerb
allograft
reject
microvesicl
also
promot
innat
immun
respons
virus
exampl
observ
hiv
wherebi
transfer
particular
antivir
cytidin
deaminas
via
exosom
inhibit
hiv
replic
addit
viruslik
vesicl
use
vaccin
strategi
recent
chimer
viruslik
vesicl
engin
use
mixtur
coronaviru
influenza
protein
function
potenti
sever
acut
respiratori
syndrom
sar
viru
vaccin
virus
use
variou
microvesicl
transport
mechan
surviv
strategi
case
host
immun
system
util
microvesicl
cell
signal
host
protect
microvesicl
directli
activ
suppress
cellular
respons
induc
facilit
infect
transfer
materi
improv
hinder
host
immun
recognit
strategi
exploit
develop
virusbas
therapi
oncolyt
virus
arm
therapeut
gene
current
evalu
safeti
efficaci
cancer
therapi
would
interest
determin
whether
microvesicl
alter
efficaci
oncolyt
virus
type
viral
gene
deliveri
vector
recent
work
show
microvesicl
load
adenoassoci
viral
aav
vector
effici
gene
deliveri
open
new
window
microvesicl
therapeut
field
sever
human
pathogen
virus
known
abil
lie
dormant
host
immun
system
hsv
ebv
perhap
best
known
exampl
case
hsv
due
abil
viru
enter
latent
state
nucleu
sensori
neuron
express
viral
antigen
disturb
physiolog
neuron
latenc
singl
transcript
gener
encod
precursor
four
distinct
hsv
mirna
act
suppress
viru
replic
human
herpesviru
better
known
ebv
larg
due
incomplet
erad
viru
earli
primari
infect
gamma
herpesvirus
includ
ebv
develop
varieti
strategi
exploit
hostcel
regulatori
pathway
lead
perman
infect
host
pathway
deregul
usual
undamag
herp
infect
predispos
diseaseinclud
enceph
autoimmun
cancer
recent
demonstr
ebv
exploit
endosomalexosom
pathway
balanc
intracellular
signal
infect
b
cell
control
epigenet
chang
uninfect
neighbor
cell
via
microvesicl
envelop
virus
herp
viru
famili
human
cmv
ebv
depend
interact
cellular
endosom
membran
system
replic
interestingli
matur
virion
releas
togeth
intern
vesicl
mvb
cellular
endosomalexosom
pathway
thu
mani
herpesvirus
gener
seem
exploit
endosom
pathway
microvesicl
viru
product
releas
immun
evas
howev
find
virus
ebv
modul
hostcellular
pathway
directli
involv
viru
product
need
investig
first
human
tumor
viru
identifi
ebv
mani
aspect
extraordinarili
benign
pathogen
best
known
caus
agent
kiss
diseas
infecti
mononucleosi
estim
world
popul
persist
infect
ebv
ebv
life
cycl
begin
exchang
saliva
ebv
virion
seem
preferenti
infect
rest
b
cell
secondari
lymphoid
organ
tonsil
occasion
isol
epitheli
cell
also
becom
infect
presum
sustain
lytic
replic
requir
viral
shed
saliva
transmiss
new
host
reach
near
univers
preval
without
harm
host
ebv
relat
persist
herpesvirus
evolv
complex
strategi
encourag
immun
recognit
prolif
potenti
oncogen
stage
life
cycl
elegantli
avoid
immun
recognit
stage
go
hide
upon
initi
infect
mantl
zone
germin
center
gc
newli
infect
b
cell
undergo
multipl
differenti
stage
tight
interact
surround
stroma
cell
interestingli
ebv
facilit
essenti
interact
matur
b
cell
instanc
upregul
crucial
gc
reactionassoci
protein
integr
part
ebv
life
cycl
ie
mimick
gctype
reaction
requir
tight
growth
regul
specif
ebv
latenc
gene
express
program
latenc
iii
promot
rapid
growth
prolifer
infect
cell
activ
strategi
expand
infect
pool
b
cell
without
need
lytic
replic
may
advantag
normal
condit
rais
chanc
turningon
malign
growth
viral
latenc
program
properli
control
inde
cell
progress
memori
cell
shut
growth
program
remain
prolif
phase
give
rise
ebvposit
lymphoma
kill
host
thu
restrict
viral
propag
spread
addit
ebv
infect
stage
may
also
predispos
autoimmun
inappropri
surviv
signal
may
interfer
neg
select
selfreact
b
cell
note
immunesuppress
individu
increas
risk
develop
ebvdriven
lymphoma
reflect
import
lifelong
potent
antiebv
tcell
respons
abil
ebv
persist
despit
vigor
tcell
respons
indic
ebv
escap
adapt
immun
system
may
part
exploit
endosomalexosom
pathway
secret
tcell
inhibitori
exosom
secret
ebvposit
tumor
exosom
carri
immuneevas
protein
includ
viral
protein
high
amount
galectin
caus
massiv
apoptosi
ebvspecif
tcell
via
specif
interact
tcell
immunoglobulin
neg
regul
cell
macrophag
activ
inhibit
antiebv
immun
respons
believ
promot
progress
ebvposit
malign
hodgkin
diseas
hd
nasopharyng
carcinoma
npc
vallhov
et
al
studi
interact
exosom
secret
ebvdriven
lymphoblastoid
cell
line
lcl
peripher
blood
b
cell
prolifer
vitro
lcl
latent
small
proport
cell
lytic
stage
exosomecel
interact
could
inhibit
specif
antibodi
major
envelop
protein
ebv
b
cell
indic
interact
b
cell
exosom
specif
exosomecel
interact
may
exploit
exosomebas
anticanc
therapi
exampl
deliv
protein
leukem
b
blast
cell
render
immunogen
cell
addit
protein
clear
microvesicl
mani
cell
type
carri
transport
function
rna
molecul
ebv
first
viru
discov
encod
small
regulatori
mirna
ebv
encod
stagger
viral
mirna
speci
deriv
two
major
gene
cluster
viral
genom
import
role
ebv
persist
next
gener
sequenc
indic
ebvencod
mirna
make
larg
fraction
total
cellular
mirna
ebvinfect
cell
encompass
differ
mirna
speci
similar
result
found
mirna
profil
exosom
ebvdriven
lcl
cell
pegtel
et
al
unpublish
result
consist
idea
viral
mirna
manipul
gene
regul
host
cellular
pathway
also
exploit
exosom
mirna
commun
pathway
inde
discoveri
ebvencod
regulatori
mirna
ebvmirna
resid
within
lumen
exosom
indic
novel
mechan
exosom
exert
inhibitori
effect
name
translat
repress
target
gene
noninfect
recipi
cell
via
exosom
ebv
mirna
earlier
studi
mice
suggest
intact
exosom
ebvinfect
cell
strong
physiolog
effect
vivo
consist
idea
lumin
content
exosom
biolog
signific
apart
protein
lipid
make
surfac
subsequ
studi
demonstr
ebvinfect
cancer
ec
also
secret
ebvmirna
presum
within
exosom
due
lack
accur
vivo
model
human
ebv
infect
difficult
investig
mechan
control
releas
ebvmirna
exosom
determin
whether
contribut
viral
persist
healthi
infect
individu
howev
ebvencod
mirna
transport
infect
b
cell
noninfect
ebvdna
neg
cell
monocyt
support
idea
horizont
mirna
transfer
human
thu
viral
mirna
exosom
may
contribut
sustain
persist
viru
infect
deliveri
mirna
noninfect
respond
cell
lead
inactiv
anergi
destruct
consist
recent
data
suggest
exosom
effici
transport
mirna
immunolog
synaps
interact
cell
apc
similar
known
concern
antigen
exchang
studi
underway
establish
whether
ebv
exploit
special
intercellular
contact
effici
posttranscript
control
neighbor
respond
immun
cell
possibl
mechan
immun
escap
hiv
discuss
topic
microvesicl
field
mani
year
hypothes
hiv
may
microvesicl
featur
microvesicl
also
describ
immun
modulatori
function
hivinfect
cell
expand
infect
hiv
gould
et
al
postul
envelop
microvesicl
system
benefit
assembl
subsequ
exit
interestingli
inhibitor
identifi
block
bud
shed
microvesicl
hiv
particl
addit
peptid
identifi
prevent
interact
hiv
nef
key
protein
hiv
life
mortalin
cellular
heat
shock
protein
result
inhibit
releas
hiv
nefcontain
microvesicl
care
analysi
howev
indic
although
hiv
exploit
certain
protein
also
play
role
exosom
format
via
mvb
hiv
assembl
necessarili
use
logist
system
exosom
importantli
establish
hiv
bud
occur
mostli
plasma
membran
within
mvb
interestingli
hiv
recruit
member
mvb
escrt
complex
proper
hiv
bud
plasma
membran
cell
hiv
releas
appear
independ
exosom
monocytederiv
macrophag
hiv
bud
endosom
howev
sever
studi
highlight
bud
also
macrophag
occur
primari
plasma
membran
thu
controversi
site
product
viru
assembl
macrophag
mostli
favor
plasma
membran
hiv
releas
dendrit
cell
may
trigger
signal
similar
exosom
releas
secret
hiv
endocyt
compart
dendrit
cell
result
hiv
releas
upon
interact
cell
howev
endocyt
compart
also
describ
connect
extracellular
space
suggest
invagin
domain
distinct
classic
endocyt
vesicl
moreov
microvesicl
releas
cell
treat
ceramid
inhibitor
affect
treatment
previous
report
howev
virus
microvesicl
produc
ceramidedefici
cell
fail
captur
matur
dendrit
cell
therefor
research
warrant
specif
site
hiv
assembl
particular
cell
type
extent
endosom
compart
play
role
hiv
life
cycl
well
possibl
converg
hiv
shed
microvesicl
pathway
seem
like
hiv
simpli
adapt
use
certain
host
factor
differ
exit
modal
may
vari
among
differ
type
cell
well
differ
condit
continu
interest
studi
retrovir
famili
includ
endogen
retrovirus
order
determin
whether
microvesicl
cargo
system
perhap
remnant
previou
retrovir
infect
happen
earlier
element
use
opportunist
set
retrovirus
hiv
overlap
pathway
consequ
use
overlap
machineri
releas
result
phenotyp
similar
microvesicl
retrovirus
potenti
interfer
antihiv
strategi
instanc
hiv
releas
cell
similar
glycom
properti
tcell
microvesicl
argu
common
origin
indic
phenotyp
similar
research
converg
microvesicl
hiv
pathway
may
improv
understand
process
propel
develop
new
antivir
drug
direct
hiv
role
microvesicl
hiv
infect
yet
extens
studi
appear
involv
hiv
infect
enhanc
resist
depend
cell
origin
microvesicl
deriv
hivinfect
cell
report
contain
hiv
coreceptor
allow
enhanc
hiv
infect
cell
moreov
microvesicl
megakaryocyt
platelet
contain
upon
transfer
confer
suscept
cell
normal
resist
hiv
infect
addit
hiv
replic
hiv
nef
protein
alter
exosom
pathway
increas
number
intracellular
vesicl
mvb
hiv
nefinduc
microvesicl
releas
infect
noninfect
cell
induc
apoptosi
cell
convey
resist
hiv
infect
transfer
nef
viral
compon
microvesicl
may
repres
import
mechan
immun
evas
virus
addit
exosom
contain
cytidin
deaminas
part
cellular
antivir
system
retrovirus
upon
transfer
recipi
cell
via
exosom
inhibit
hiv
replic
mhc
class
ii
molecul
found
microvesicl
hivinfect
cell
possibl
serv
silenc
immun
respons
microvesicl
deriv
cell
act
suppress
hiv
replic
moreov
exosom
associ
hiv
deriv
dendrit
cell
significantli
enhanc
hiv
infect
cell
conclus
microvesicl
hivinfect
cell
well
noninfect
cell
play
import
role
hiv
replic
dissemin
therefor
interfer
microvesiclemedi
signal
could
possibl
har
halt
hiv
infect
retrotransposon
element
line
alu
human
endogen
retrovirus
herv
make
human
genom
play
import
role
genom
evolut
virallik
element
infect
germ
cell
human
genom
million
year
ago
becam
stabl
part
inherit
genet
materi
although
line
element
inact
number
activ
one
remain
abl
jump
new
locat
genom
contribut
genom
instabl
event
import
effect
genom
exampl
inactiv
gene
alter
gene
express
facilit
random
insert
new
cdna
copi
genom
integr
pseudogen
mani
tumor
cell
also
releas
retrovirallik
microvesicl
contain
activ
retrotransposon
sequenc
hervk
recent
tumorderiv
microvesicl
shown
enrich
retrotransposon
element
alu
hervk
furthermor
hervk
transfer
microvesicl
normal
huvec
show
increas
hervk
level
hour
follow
exposur
tumor
microvesicl
addit
mous
retrovir
rna
packag
retroviru
vector
mous
packag
cell
line
transfer
human
cell
infect
vector
mous
sever
stop
codon
region
encod
gene
gag
pol
env
therebi
inhibit
abil
encod
function
protein
howev
transfer
mrna
togeth
tissu
factor
tf
human
melanoma
cell
serv
induc
metastat
potenti
chang
phenotyp
appar
occur
format
complex
proteinassoci
splice
factor
psf
protein
repress
transcript
insulinlik
growth
induc
gene
dissoci
complex
allow
transcript
proceed
three
human
gene
affect
mrna
oncogen
suggest
transfer
retrovir
rna
sequenc
catastroph
effect
recipi
cell
song
et
al
identifi
human
retrotransposon
sequenc
ident
mous
suggest
human
transfer
microvesicl
could
similar
effect
transcript
long
interspers
element
line
notabl
human
genom
sever
studi
indic
subset
element
still
activ
expand
number
sequenc
within
human
genom
retrotransposit
activ
subpopul
term
transcript
activ
ta
approxim
million
year
old
high
level
insert
polymorph
human
popul
new
insert
may
intoler
lethal
therefor
elimin
other
may
result
phenotyp
toler
diseas
coffinlowri
syndrom
choroideremia
still
other
associ
induct
cancer
exampl
lung
cancer
high
level
polymorph
element
indic
continu
profound
effect
human
genom
recent
evid
suggest
microvesicl
may
potenti
rout
deliveri
element
microvesiclemedi
trojan
horselik
transfer
transposon
could
perhap
allow
stealthi
dissemin
retrotransposon
especi
tumor
set
avoid
immunerecognit
achiev
long
distanc
deliveri
herv
also
enter
human
genom
million
year
ago
compris
human
genom
consist
gag
pol
env
sequenc
flank
two
long
termin
repeat
sequenc
silent
acquir
mutat
delet
cours
evolut
produc
intact
albeit
noninfecti
retrovir
particl
sequenc
still
transcript
activ
associ
diseas
lymphoma
breast
cancer
cancer
hypomethyl
genom
seem
predominantli
affect
retrotransposon
sequenc
perhap
highli
abund
human
genom
allow
increas
transcript
especi
case
recent
entrant
also
happen
element
intact
code
potenti
inde
retrovirallik
microvesicl
found
cancer
patient
notabl
lymphoma
breast
cancer
teratoma
expect
patient
also
high
level
revers
transcriptas
viral
gag
env
protein
rna
tumor
cell
retroviruslik
microvesicl
releas
circul
tumor
microvesicl
cultur
tumor
cell
also
shown
enrich
retrotransposon
rna
dna
revers
transcriptas
suggest
subpopul
microvesicl
may
inde
retrovir
origin
summari
review
deal
extracellular
exosom
shed
pathway
assembl
releas
retrotransposon
element
virus
figur
summar
herpesvirus
ebv
hsv
origin
nucleu
merg
microvesicl
pathway
sever
protein
use
exosom
product
use
herpesvirus
function
releas
also
converg
pathway
may
explain
observ
viruslik
particl
exosom
shed
microvesicl
contain
viral
protein
nucleic
acid
similar
observ
made
retrovirus
retrotransposon
element
circul
microvesicl
contain
retrotransposon
rna
found
cancer
patient
remain
investig
extent
exosom
shed
microvesicl
remnant
previou
retrovir
colon
review
note
observ
retrovir
well
retrotransposon
element
microvesicl
perhap
allow
dissemin
nucleic
acid
sequenc
use
microvesicl
pathway
element
virus
hiv
may
suggest
intric
coevolut
differ
endogen
exogen
retro
viru
subtyp
virus
use
microvesicl
pathway
assembl
releas
also
capabl
exploit
highli
complex
microvesicl
commun
system
intercellular
set
simplifi
figur
viral
infect
microvesicl
variou
effect
differ
type
cell
either
limit
viral
infect
enhanc
thu
pictur
emerg
virus
microvesicl
codepend
pleiotrop
entiti
research
need
differenti
function
differ
subtyp
microvesicl
crosstalk
relat
immun
respons
outcom
viral
infect
